Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency updates on development of its policy on publication and access to clinical-trial data 13 November 2013Press releaseCorporateMedicines Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 5-7 November 2013 8 November 2013Press releaseVeterinary Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 November 2013 8 November 2013NewsHumanPharmacovigilance PRAC recommends using acipimox only as additional or alternative treatment to lower high triglyceride levels 8 November 2013Press releaseHumanPharmacovigilance PRAC recommends suspension of diacerein-containing medicines 8 November 2013Press releaseHumanPharmacovigilance PRAC updates on the risks of serious vascular occlusive events associated with cancer medicine Iclusig 8 November 2013Press releaseCorporatePharmacovigilance Briefing meetings of the EMA Innovation Task Force now open to veterinary medicines 8 November 2013NewsVeterinaryInnovation European Medicines Agency website unavailable Saturday 9 November 8 November 2013NewsCorporateMedicines Workshop on regulatory options in fight against antimicrobial resistance takes place today 8 November 2013NewsCorporate New EMA guidance on development of antibacterials to help in the fight against multidrug-resistant pathogens 7 November 2013Press releaseHuman 1 … 213 214 215 216 217 Page 217 of 384 218 219 220 221 … 384
European Medicines Agency updates on development of its policy on publication and access to clinical-trial data 13 November 2013Press releaseCorporateMedicines
Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 5-7 November 2013 8 November 2013Press releaseVeterinary
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 November 2013 8 November 2013NewsHumanPharmacovigilance
PRAC recommends using acipimox only as additional or alternative treatment to lower high triglyceride levels 8 November 2013Press releaseHumanPharmacovigilance
PRAC recommends suspension of diacerein-containing medicines 8 November 2013Press releaseHumanPharmacovigilance
PRAC updates on the risks of serious vascular occlusive events associated with cancer medicine Iclusig 8 November 2013Press releaseCorporatePharmacovigilance
Briefing meetings of the EMA Innovation Task Force now open to veterinary medicines 8 November 2013NewsVeterinaryInnovation
European Medicines Agency website unavailable Saturday 9 November 8 November 2013NewsCorporateMedicines
Workshop on regulatory options in fight against antimicrobial resistance takes place today 8 November 2013NewsCorporate
New EMA guidance on development of antibacterials to help in the fight against multidrug-resistant pathogens 7 November 2013Press releaseHuman